Bayer lifts sales and earnings again Information about the Cover Picture
Bayer lifts sales and earnings again

News of the third quarter 2010

Bayer Schering Pharma has announced the upcoming launch in China of Betaferon®
Better treatment for MS patients in China

» more

Agreements between Bayer CropScience and the Oil Crops Research Institute in China

Increasing oil content and combating disease in oilseed rape

» more

1:18 min.

Focus

Im Fokus

New Chairman of the Board of Management of Bayer AG

Change at the top
Another milestone in the history of the Bayer Group was reached on October 1, when Werner Wenning handed over the chairmanship of the Bayer AG Board of Management to Dr. Marijn Dekkers. Dekkers stressed that “My goal is the same as that of all my predecessors. We want
the best for Bayer and Bayer’s stakeholders.”
» more

Key Data

Bayer Group
Group sales rose by 16.1% to €8,581million (Q3 2009: €7,392 million). Read more about Net Sales, EBITDA, EBIT, Net income, Cash flow, Non-operating result, Number of Employees.
» more

Bayer Stock

Investor Information
The price of Bayer shares trended positively in the third quarter of 2010, increasing by 11.2%.
» more

Management Report

Overview of Sales, Earnings and Financial Position
The Bayer Group achieved significant gains in sales and earnings in the third quarter of 2010,
as in the two preceding quarters. The continued recovery in the Material Science business was a
key factor in this improvement.
» more

Financial Statements

Bayer Group Consolidated Income Statements
Comprehensive Income, Financial Position, Bayer Group Consolidated Statements of Cash Flows.
» more
http://www.stockholders-newsletter-q3-2010.bayer.com/en/homepage.aspx

Copyright © Bayer AG

Print Page

Search

Download Center

Publications

Services

Special Interest